IMAGING

Philips and Mass General Brigham: Advancing Patient Care

Discover how Philips and Mass General Brigham are transforming healthcare with innovative AI solutions for better patient outcomes.

KA Imaging’s Premium Dual-Energy Mobile System Now Available For Sale In Europe Reveal Mobi Pro Has Received the CE Mark

The Reveal Mobi Pro ™ integrates KA Imaging’s Reveal™ 35C detector with SpectralDR® technology into a complete mobile X-ray solution.

Subtle Medical Reports: SubtleHD™ Awarded FDA Clearance, Setting a New Benchmark for MRI Image Quality and Speed

With FDA clearance of SubtleHD™, Subtle Medical launches Subtle-ELITE™, an industry-first AI package designed to achieve superior image quality, unprecedented speed, and workflow automation.

Philips, World Bank, and Ukraine Ministry of Health Announce Successful Deployment of Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients

“This program is saving lives, reducing disability, and changing the futures of stroke patients,” said Dr. Dmytro Lebedynets, a neurologist at Feofaniya Clinical Hospital and consultant on stroke to the World Bank and the Ministry of Health of Ukraine. “With these advanced tools, we can deliver timely and precise life-saving care, even in emergencies. It’s a game-changer for our patients. Now all the regions of our country will be able to provide the full spectrum of care to stroke patients.”

Philips and AWS Expand Strategic Collaboration to Advance HealthSuite Cloud Services and Power Generative AI Workflows

“The collaboration between Philips and AWS gives healthcare providers scalable, secure-by-design cloud-enabled solutions to accelerate healthcare innovation,” said Matt Garman, CEO of AWS. “Combining Philips’ healthcare informatics portfolio with AWS generative AI capabilities gives clinicians access to imaging insights so they can deliver more effective and efficient care to patients anywhere, anytime, with best-in-class security and privacy.”

Elucid Announces Fifth Medicare Administrative Contractor to Cover AI Coronary Plaque Analysis

“This latest expansion of coverage by Noridian means that even more patients could be positively impacted by PlaqueIQ, which offers the only non-invasive measurement of lipid-rich necrotic core, a vulnerable, high-risk component of plaque that can lead to heart attack and stroke,”4 said Kelly Huang, CEO of Elucid. “These recent decisions from five of the seven MACs recognize the importance of new technologies like ours that can help quantify and classify coronary artery plaque to help physicians reduce the clinical and economic burden of cardiovascular disease.”

Mediso Introduces True Theranostic TheraMAX SPECT/CT

The TheraMAX is equipped with three, large surface detectors (up to 5x larger than 12-detector CZT systems) surrounding the patients completely (360°). The 15.9mm thick NaI crystals ensure improved sensitivity for high energy photons, while the high-density sensor arrangement (123 PMT per detector head) allows high spatial resolution leading to PET-like image quality in all NM applications.

Pioneering Hospitals Take Major Steps Towards Decarbonizing Healthcare with Philips

“Good healthcare has to be environmentally sustainable, which means words and good intentions urgently need to be turned into positive actions. Philips is committed to co-creating solutions that drive measurable, impactful change. By working with like-minded action leaders around the world, sharing with them our expertise in sustainable healthcare operations, we are helping them to take critical and tangible steps toward a greener future, while at the same time enhancing patient care,” said Robert Metzke, Global Head of Sustainability at Philips.

IVUS and iFR Technologies Receive Top-level Recognition in New ESC Guidelines, Reinforcing their Role In Optimizing Coronary Interventions and Patient Outcomes

The latest updates to these ESC guidelines emphasize the robust clinical evidence supporting the use of intravascular ultrasound (IVUS) and instantaneous wave-free ratio (iFR), both of which have demonstrated significant benefits in improving patient outcomes through numerous large-scale randomized trials like DEFINE FLAIR and iFR SWEDEHEART. The updates were announced at the recent ESC Congress in London, five years after the last update in 2019, and simultaneously published in the European Heart Journal.
Medical Device News Magazinespot_img